Skip to content
Home/Companies/Pharma/Archimica
Archimica

Archimica

Pharma·Italy·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns Archimica?

Archimica is an Italian Pharma company, now owned by PI HealthSciences, which acquired it in 2023 from LIVIA Group.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
LIVIA Group
Investor
LIVIA Group
LIVIA Corporate Development · 2013 · Evergreen

Key facts

HQItaly
SectorPharma
StatusAcquired
Websitewww.archimica.com
Exit Type
Trade Sale
Buyer
PI HealthSciences
Exit Year
2023

More from LIVIA Corporate Development

Other portfolio companies in the same fund.

Westpole
Exited 2023
IT ServicesItaly· 2020
to Cegeka (Italy) / Prodware (Belux)
ALUCOM
Alucom
Exited 2025
IndustrialsGermany· 2018
to VTA Group
Baden Board and Packaging
Exited 2019
IndustrialsGermany· 2018
to MARPERGER Group
Tingari
Exited 2022
Business ServicesFrance· 2018
to ManpowerGroup
Refel
Exited 2022
IndustrialsItaly· 2017
to Sisecam
Coflace Food
Exited 2017
ConsumerNetherlands· 2016
to Existing management of Coflace Food BV

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Archimica?

Archimica is now owned by PI HealthSciences, which acquired it in 2023 from LIVIA Group.

When did PI HealthSciences acquire Archimica?

PI HealthSciences acquired Archimica in 2023, buying from LIVIA Group.

Who did Archimica sell to?

LIVIA Group sold Archimica to PI HealthSciences in 2023 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue